[开放获取]    中国痤疮瘢痕治疗专家共识（2021）

doi:10.35541/cjd.20210182

中华皮肤科杂志 ›› 2021, Vol. 54 ›› Issue (9): 747-756.doi: 10.35541/cjd.20210182

[开放获取] 中国痤疮瘢痕治疗专家共识（2021）

中华医学会医学美学与美容学分会激光美容学组中华医学会皮肤性病学分会美容激光学组中国医师协会美容与整形医师分会激光学组

中华医学会医学美学与美容学分会激光美容学组中华医学会皮肤性病学分会美容激光学组中国医师协会美容与整形医师分会激光学组

收稿日期:2021-03-04 修回日期:2021-07-28 发布日期:2021-09-02
通讯作者: 杨森 E-mail:yang2004sen@163.com

Consensus on treatment of acne scars in China （2021）

Laser Cosmetology Group, Medical Aesthetics and Cosmetology Branch of Chinese Medical Association; Cosmetic Laser Group, Chinese Society of Dermatology; Laser Group, Cosmetic and Plastic Surgeon Branch of Chinese Medical Doctor Association

Laser Cosmetology Group, Medical Aesthetics and Cosmetology Branch of Chinese Medical Association; Cosmetic Laser Group, Chinese Society of Dermatology; Laser Group, Cosmetic and Plastic Surgeon Branch of Chinese Medical Doctor Association

Received:2021-03-04 Revised:2021-07-28 Published:2021-09-02
Contact: Yang Sen E-mail:yang2004sen@163.com

摘要/Abstract

摘要： 【摘要】痤疮瘢痕是由于炎症反应、感染、处理不当等因素导致痤疮患者在痤疮皮损处遗留瘢痕，在临床上发病率高，治疗困难。目前治疗痤疮瘢痕的方法众多，包括药物、光电技术、外科、填充术、化学剥脱术、中医疗法、生物疗法、微针疗法等，且不断有新方法涌现，但仍然缺乏高质量的相关临床研究，存在治疗方法不统一、疗效不理想等问题。针对不同时期、不同类型的痤疮瘢痕，如何选择合适的方法进行综合治疗，是临床工作中关注的热点和难点。本共识从循证医学角度出发，旨在为临床治疗痤疮瘢痕提供参考。

关键词: 寻常痤疮, 瘢痕, 治疗, 诊疗准则

Abstract: 【Abstract】 Acne scars are caused by inflammatory reactions, infections, improper handling of acne lesions, etc, and occur at a high incidence rate. Their treatment is difficult. Currently, there are many methods to treat acne scars, including medicines, photoelectric technology, surgery, filling, chemical peeling, traditional Chinese medicine, biotherapy, microneedle therapy, etc., and many new methods are constantly emerging. However, there are still many difficulties, such as the lack of high-quality clinical studies, non-uniform treatment methods and unsatisfactory therapeutic effects. It remains a challenge and a research hotspot to choose appropriate methods for comprehensive treatment of different types of acne scars at different stages in clinical practice. From the perspective of evidence-based medicine, this consensus aims to provide a reference for the treatment of acne scars in clinical practice.

Key words: Acne vulgaris, Cicatrix, Therapy, Practice guideline

中华医学会医学美学与美容学分会激光美容学组中华医学会皮肤性病学分会美容激光学组中国医师协会美容与整形医师分会激光学组. [开放获取] 中国痤疮瘢痕治疗专家共识（2021）[J]. 中华皮肤科杂志, 2021,54(9):747-756. doi:10.35541/cjd.20210182

Laser Cosmetology Group, Medical Aesthetics and Cosmetology Branch of Chinese Medical Association, Cosmetic Laser Group, Chinese Society of Dermatology, Laser Group, Cosmetic and Plastic Surgeon Branch of Chinese Medical Doctor Association. Consensus on treatment of acne scars in China （2021）[J]. Chinese Journal of Dermatology, 2021, 54(9): 747-756.doi:10.35541/cjd.20210182

参考文献 40

［1］	Tan J, Kang S, Leyden J. Prevalence and risk factors of acne scarring among patients consulting dermatologists in the USA［J］. J Drugs Dermatol, 2017,16（2）:97⁃102.
［2］	Wu TQ, Mei SQ, Zhang JX, et al. Prevalence and risk factors of facial acne vulgaris among Chinese adolescents［J］. Int J Adolesc Med Health, 2007,19（4）:407⁃412. doi: 10.1515/ijamh. 2007.19.4.407.
［3］	Fabbrocini G, Annunziata MC, D′Arco V, et al. Acne scars: pathogenesis, classification and treatment［J］. Dermatol Res Pract, 2010, 2010:893080. doi: 10.1155/2010/893080.
［4］	Bhargava S, Cunha PR, Lee J, et al. Acne scarring management: systematic review and evaluation of the evidence［J］. Am J Clin Dermatol, 2018,19（4）:459⁃477. doi: 10.1007/s40257⁃018⁃0358⁃5.
［5］	Akoglu G, Tan C, Ayvaz DC, et al. Tumor necrosis factor α⁃308 G/A and interleukin 1 β⁃511 C/T gene polymorphisms in patients with scarring acne［J］. J Cosmet Dermatol, 2019,18（1）:395⁃400. doi: 10.1111/jocd.12558.
［6］	Moon J, Yoon JY, Yang JH, et al. Atrophic acne scar: a process from altered metabolism of elastic fibres and collagen fibres based on transforming growth factor⁃β1 signalling［J］. Br J Dermatol, 2019,181（6）:1226⁃1237. doi: 10.1111/bjd.17851.
［7］	González N, Goldberg DJ. Update on the treatment of scars［J］. J Drugs Dermatol, 2019,18（6）:550.
［8］	Clark AK, Saric S, Sivamani RK. Acne scars: how do we grade them?［J］. Am J Clin Dermatol, 2018,19（2）:139⁃144. doi: 10. 1007/s40257⁃017⁃0321⁃x.
［9］	Zaleski⁃Larsen LA, Fabi SG, McGraw T, et al. Acne scar treatment: a multimodality approach tailored to scar type［J］. Dermatol Surg, 2016,42 Suppl 2:S139⁃S149. doi: 10.1097/DSS. 0000000000000746.
［10］	Boen M, Jacob C. A review and update of treatment options using the acne scar classification system［J］. Dermatol Surg, 2019,45（3）:411⁃422. doi: 10.1097/DSS.0000000000001765.
［11］	Goodman GJ, Baron JA. Postacne scarring: a qualitative global scarring grading system［J］. Dermatol Surg, 2006,32（12）:1458⁃1466. doi: 10.1111/j.1524⁃4725.2006.32354.x.
［12］	Fearmonti R, Bond J, Erdmann D, et al. A review of scar scales and scar measuring devices［J］. Eplasty, 2010,10:e43.
［13］	Dreno B, Khammari A, Orain N, et al. ECCA grading scale: an original validated acne scar grading scale for clinical practice in dermatology［J］. Dermatology, 2007,214（1）:46⁃51. doi: 10.1159/000096912.
［14］	Goodman GJ, Baron JA. Postacne scarring⁃⁃a quantitative global scarring grading system［J］. J Cosmet Dermatol, 2006,5（1）:48⁃52. doi: 10.1111/j.1473⁃2165.2006.00222.x.
［15］	Baryza MJ, Baryza GA. The vancouver scar scale: an administration tool and its interrater reliability［J］. J Burn Care Rehabil, 1995,16（5）:535⁃538. doi: 10.1097/00004630⁃199509 000⁃00013.
［16］	Draaijers LJ, Tempelman FR, Botman YA, et al. The patient and observer scar assessment scale: a reliable and feasible tool for scar evaluation［J］. Plast Reconstr Surg, 2004,113（7）:1960⁃1965; discussion 1966⁃1967. doi: 10.1097/01.prs.0000122207. 28773.56.
［17］	Anderson RR, Donelan MB, Hivnor C, et al. Laser treatment of traumatic scars with an emphasis on ablative fractional laser resurfacing: consensus report［J］. JAMA Dermatol, 2014,150（2）:187⁃193. doi: 10.1001/jamadermatol.2013.7761.
［18］	周展超. 皮肤美容激光与光子治疗［M］. 北京: 人民卫生出版社, 2009:278⁃279.
［19］	Gheisari M, Iranmanesh B, Saghi B. Blunt cannula subcision is more effective than Nokor needle subcision for acne scars treatment［J］. J Cosmet Dermatol, 2019,18（1）:192⁃196. doi: 10.1111/jocd.12523.
［20］	吴晓琰, 陈晓栋, 许攀, 等. 瘢痕疙瘩下埋植扩张器治疗大面积瘢痕疙瘩［J］. 临床皮肤科杂志, 2018,47（12）:817⁃822. doi: 10.16761/j.cnki.1000⁃4963.2018.12.020.
［21］	Stiegler J, Weinste M. Therapies for acne scarring［J］. Adv Cosmet Surg, 2020,3（1）:15⁃24. doi.org/10.1016/j.yacs.2020.01. 002.
［22］	Zhang Y, Cai J, Zhou T, et al. Improved long⁃term volume retention of stromal vascular fraction gel grafting with enhanced angiogenesis and adipogenesis［J］. Plast Reconstr Surg, 2018,141（5）:676e⁃686e. doi: 10.1097/PRS.0000000000004312.
［23］	Abou Eitta RS, Ismail AA, Abdelmaksoud RA, et al. Evaluation of autologous adipose⁃derived stem cells vs. fractional carbon dioxide laser in the treatment of post acne scars: a split⁃face study［J］. Int J Dermatol, 2019,58（10）:1212⁃1222. doi: 10.1111/ijd.14567.
［24］	Kontochristopoulos G, Platsidaki E. Chemical peels in active acne and acne scars［J］. Clin Dermatol, 2017,35（2）:179⁃182. doi: 10.1016/j.clindermatol.2016.10.011.
［25］	Handog EB, Datuin MS, Singzon IA. Chemical peels for acne and acne scars in asians: evidence based review［J］. J Cutan Aesthet Surg, 2012,5（4）:239⁃246. doi: 10.4103/0974⁃2077.104911.
［26］	Garg VK, Sinha S, Sarkar R. Glycolic acid peels versus salicylic⁃mandelic acid peels in active acne vulgaris and post⁃acne scarring and hyperpigmentation: a comparative study［J］. Dermatol Surg, 2009,35（1）:59⁃65. doi: 10.1111/j.1524⁃4725.2008.34383.x.
［27］	陈达灿, 曲剑华. 中医皮肤科学［M］. 北京: 人民卫生出版社, 2020:415.
［28］	Chen Q, Yu N, Liu Z, et al. The clinical efficacy of recell® autologous cell regeneration techniques combined with dermabrasion treatment in acne scars［J］. Aesthetic Plast Surg, 2020,44（2）:535⁃542. doi: 10.1007/s00266⁃019⁃01481⁃8.
［29］	Soliman YS, Horowitz R, Hashim PW, et al. Update on acne scar treatment［J］. Cutis, 2018,102（1）:21;25;47;48.
［30］	Ibrahim ZA, Eltatawy RA, Ghaly NR, et al. Autologus bone marrow stem cells in atrophic acne scars: a pilot study［J］. J Dermatolog Treat, 2015,26（3）:260⁃265. doi: 10.3109/09546634. 2014.946379.
［31］	Villani A, Carmela Annunziata M, Antonietta Luciano M, et al. Skin needling for the treatment of acne scarring: a comprehensive review［J］. J Cosmet Dermatol, 2020,19（9）:2174⁃2181. doi: 10.1111/jocd.13577.
［32］	Chernoff G. The utilization of a nitric oxide generating serum in the treatment of active acne and acne scarred patients［J］. Int J Pharma Anal Acta, 2020, 3（1）: 10⁃14.
［33］	Dréno B, Bissonnette R, Gagné⁃Henley A, et al. Long⁃term effectiveness and safety of up to 48 weeks′ treatment with topical adapalene 0.3%/Benzoyl Peroxide 2.5% Gel in the prevention and reduction of atrophic acne scars in moderate and severe facial acne［J］. Am J Clin Dermatol, 2019,20（5）:725⁃732. doi: 10.1007/s40257⁃019⁃00454⁃6.
［34］	Rocha MA, Bagatin E. Skin barrier and microbiome in acne［J］. Arch Dermatol Res, 2018,310（3）:181⁃185. doi: 10.1007/s00403⁃017⁃1795⁃3.
［35］	Jordan RE, Cummins CL, Burls AJ, et al. Laser resurfacing for facial acne scars［J］. Cochrane Database Syst Rev, 2001,（1）:CD001866. doi: 10.1002/14651858.CD001866.
［36］	Katz BE. The fate of active acne and acne scars following treatment with fractional radiofrequency［J］. J Drugs Dermatol, 2019,18（12）:1268⁃1272.
［37］	Abdel Hay R, Shalaby K, Zaher H, et al. Interventions for acne scars［J］. Cochrane Database Syst Rev, 2016,4（4）:CD011946. doi: 10.1002/14651858.CD011946.pub2.
［38］	Khalid FA, Mehrose MY, Saleem M, et al. Comparison of efficacy and safety of intralesional triamcinolone and combination of triamcinolone with 5⁃fluorouracil in the treatment of keloids and hypertrophic scars: randomised control trial［J］. Burns, 2019,45（1）:69⁃75. doi: 10.1016/j.burns.2018.08.011.
［39］	Mankowski P, Kanevsky J, Tomlinson J, et al. Optimizing radiotherapy for keloids: a meta⁃analysis systematic review comparing recurrence rates between different radiation modalities［J］. Ann Plast Surg, 2017,78（4）:403⁃411. doi: 10. 1097/SAP.0000000000000989.
［40］	Lee KC, Wambier CG, Soon SL, et al. Basic chemical peeling: Superficial and medium⁃depth peels［J］. J Am Acad Dermatol, 2019,81（2）:313⁃324. doi: 10.1016/j.jaad.2018.10.079.

[1]	侯晓媛吴南辉徐明圆刘业强. JAK抑制剂巴瑞替尼治疗环状肉芽肿1例[J]. 中华皮肤科杂志, 2024, 57(5): 461-462.
[2]	《乳房外Paget病诊治专家共识（版）》编写委员会专家组. [开放获取] 乳房外Paget病诊治专家共识（2024版）[J]. 中华皮肤科杂志, 2024, 57(5): 400-408.
[3]	中国医师协会皮肤科医师分会. [开放获取] 慢性瘙痒管理指南（2024版）[J]. 中华皮肤科杂志, 2024, 57(5): 387-399.
[4]	中国“一带一路”皮肤病专病联盟分枝杆菌病研究联盟中国麻风防治协会皮肤性病检验与诊断分会. [开放获取] 中国皮肤结核临床诊疗专家共识（2024版）[J]. 中华皮肤科杂志, 2024, 57(5): 426-434.
[5]	中国医师协会皮肤科医师分会中国中西医结合学会皮肤性病学分会. 红皮病型银屑病诊疗中国专家共识（2024版）[J]. 中华皮肤科杂志, 2024, 57(5): 409-417.
[6]	中国中西医结合学会皮肤性病学分会真菌学组中国耐药皮肤癣菌病诊治与防控工作组. [开放获取] 中国耐药皮肤癣菌感染诊治与防控专家共识（2024版）[J]. 中华皮肤科杂志, 2024, 57(5): 418-425.
[7]	葛新红马迎东焦亚宁刘玲玲周镁紫薇李博文. 532 nm皮秒激光治疗面部早期脂溢性角化病的疗效和安全性分析[J]. 中华皮肤科杂志, 2024, 57(4): 359-362.
[8]	宋雨晴杨楠刘琳琳冯子仪韩世新周梅娟. [开放获取] 皮肤磨削术治疗家族性良性慢性天疱疮6例临床观察[J]. 中华皮肤科杂志, 2024, 0(4): 20220278-e20220278.
[9]	岳淑珍树叶罗鸯鸯李珂瑶张圆圆汤建萍韦祝. 奥马珠单抗治疗儿童慢性荨麻疹的疗效和安全性回顾研究[J]. 中华皮肤科杂志, 2024, 57(4): 354-358.
[10]	刘祎曲莹雷文知刘晓刚潘炜华张超. 食盐封包法治疗化脓性肉芽肿25例临床观察[J]. 中华皮肤科杂志, 2024, 0(4): 20230553-e20230553.
[11]	鞠强李嘉祺. [开放获取] 寻常痤疮再认识：从发病机制到治疗策略[J]. 中华皮肤科杂志, 2024, 57(4): 289-294.
[12]	张迪敏曹成周妙妮盛安琪林福全许爱娥. 复方倍他米松注射液联合治疗后进展期非节段型白癜风稳定率及影响因素分析[J]. 中华皮肤科杂志, 2024, 57(4): 350-354.
[13]	田静邓思思宋志强. 特应性与非特应性结节性痒疹患者临床特征比较[J]. 中华皮肤科杂志, 2024, 57(4): 331-337.
[14]	李嘉祺梁梦晨吴心怡张秋婧李思彤莫小辉鞠强. 中度寻常痤疮患者皮损毛囊内表皮葡萄球菌基因序列分型的初步研究[J]. 中华皮肤科杂志, 2024, 57(4): 295-301.
[15]	严汝帆廖洁月郭子瑜姚南周文玉罗帅寒天张桂英赵明. 天疱疮发病机制和靶向治疗的研究进展[J]. 中华皮肤科杂志, 2024, 57(4): 374-378.

[开放获取] 中国痤疮瘢痕治疗专家共识（2021）

Consensus on treatment of acne scars in China （2021）

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献 40

相关文章 15

Metrics

本文评价

推荐阅读 10